Development of Powder-in-Bottle Formulation of Hydroxyurea with Methylparaben Preservative

Toggle Menu

Development of Powder-in-Bottle Formulation of Hydroxyurea with Methylparaben Preservative

November, 2013
Citation 

Shankar, G. N., Podaralla, S., Mutyam, S., Ware, R., & Parish, H. (2013, 10-14 November). Development of powder-in-bottle formulation of hydroxyurea with methylparaben preservative. Paper presented at the AAPS'13, San Antonio, TX.

Abstract 

Hydroxyurea, a chemically hydroxylated derivative of the symmetrical urea is currently under investigation for  administration to pediatric patients suffering from sickle cell anemia. The PIB clinical formulation contains sodium benzoate as a preservative and needed to be changed because the commercial syrup diluent has replaced sodium benzoate with methylparaben. A 23 screening factorial design matrix with nine different combinations was used to study the compatibility of methylparaben with hydroxyurea and excipients in open cap storage condition (40°C/75%RH) for 4 weeks. The compatibility of hydroxyurea with excipients in closed cap conditions at 30°C/65%RH and 40°C/75%RH storage for up to 6 weeks was also studied. The nine different hydroxyurea blend combinations were tested for physical appearance, thermal properties (differential scanning calorimetry), pH (blend reconstituted in Humco® simple syrup), moisture content, microbial limit testing (MLT), and antimicrobial effectiveness testing (AET). An HPLC method was developed for assaying hydroxyurea. 

In Proceedings
Search Publications
Browse by Sectors
Archive
E.g., 2018-02-19
E.g., 2018-02-19
Author